Evidence map›Paper›PMID 32133363›Full record

ArticleFrontiers in medicine2020

Insights Into the Characteristics of Sweet Syndrome in Patients With and Without Hematologic Malignancy.

Siting Zheng, Sheng Li, Shunli Tang, Yunlei Pan, Yuwei Ding, Jianjun Qiao, Hong Fang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Sweet's Syndrome as a Prodromal Manifestation of Acute Myeloid Leukemia.International journal of hematology-oncology and stem cell research · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. New Practical Aspects of Sweet Syndrome.American journal of clinical dermatology · 2022
    Review
  16. Neutrophilic Dermatoses: a Clinical Update.Current dermatology reports · 2022
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Siting ZhengDepartment of Dermatology, College of Medicine, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
Sheng LiDepartment of Dermatology, College of Medicine, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
Shunli TangDepartment of Dermatology, College of Medicine, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
Yunlei PanDepartment of Dermatology, College of Medicine, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
Yuwei DingDepartment of Dermatology, College of Medicine, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
Jianjun QiaoDepartment of Dermatology, College of Medicine, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
Hong FangDepartment of Dermatology, College of Medicine, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
First Affiliated Hospital Zhejiang University · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

hematologic malignancymortalityoutcomeSweet syndrometreatment

Identifiers

PMID32133363
PMCPMC7039821
OpenAlexW3007380914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.